Results 41 to 50 of about 106,297 (199)
, 2018 Peritoneal carcinomatosis with breast cancer origin is an uncommon situation, which usually develops late during the evolution of the disease. The development of such lesions is commonly associated with an aggressive histology (such as lobular carcinoma)
Alin BODOG +5 more
core +1 more source
, 2016 Introduction: Peritoneal cancer index (PCI) has been suggested to be the most important prognostic factors for the outcomes in colorectal peritoneal carcinomatosis (CRPC).
Liauw, W +4 more
core +1 more source
Textbook outcome in ovarian cancer and its impact on survival: comparative study
World Journal of Surgical OncologyIntroduction Patients who achieve the textbook outcome (TO) present an uneventful postoperative course. Obtaining TO has also been related to better survival in oncological patients.
Silvia Carbonell-Morote +9 more
doaj +1 more source
Florid Diffuse Peritoneal Deciduosis Mimicking Peritoneal Carcinomatosis: A Case Report
, 2016 Deciduosis is defined as the presence of decidual tissue in an ectopic site and must be distinguished from the more alarming conditions that it can simulate.
Selver Özekinci +3 more
core +1 more source
BMC Surgery, 2020 Background To review the available clinical data about the value of Indocyanine Green (ICG) fluorescence imaging for intraoperative detection of peritoneal carcinomatosis.
Gian Luca Baiocchi +5 more
doaj +1 more source
Macrophage PABPC4‐SPP1 Axis Orchestrates Immunosuppression in Colorectal Cancer
Advanced Science, EarlyView.In the CRC microenvironment, macrophage PABPC4 binds to the 3′UTR of SPP1 mRNA to stabilize its expression, thereby sustaining M2‐like immunosuppressive macrophage polarization. Concurrently, this axis suppresses CD8+ T cell effector functions via CD44 signaling, collectively fostering an immunosuppressive niche that drives tumor progression.
Meng Wang +14 more
wiley +1 more source
Peritoneal Canceromatosis in Malignant Tumors of Various Localizations. Achievements and Prospects
Креативная хирургия и онкология, 2021 Peritoneal carcinomatosis is viewed by many experts as a terminal illness with an unfavourable course and prognosis. Existing therapies are controversial and exhibit ambiguous efficacy.
Sh. Kh. Gantsev +3 more
doaj +1 more source
Journal of Surgical Oncology, EarlyView.ABSTRACT Background and Objectives Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is established for peritoneal surface malignancies, but its use in older patients is debated. We assessed CRS‐HIPEC morbidity and mortality in patients aged ≥ 70 years using a cohort of younger patients as a comparator.
Ali Ediz Kıvanç +4 more
wiley +1 more source
Efficacy of Surgical Treatment of Peritoneal Carcinomatosis in Patients with Colorectal Cancer
Galician Medical Journal, 2016 Colorectal cancer is one of the most common types of cancer in Ukraine. Prognosis for patients with peritoneal carcinomatosis is unfavorable, and life expectancy is typically less than 6 months.
T G Fetsych, A P Revura
doaj +1 more source
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis: our initial experience of implementation and detailed technique [PDF]
Ķazaķstannyṇ Klinikalyķ Medicinasy, 2019 Objective: The aim of this study is to present our initial implementation experience in peritoneal carcinomatosis treatment and the technical details of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the light of current ...
Talgat Uskenbayev +4 more
doaj +1 more source